AstraZeneca Pharma India Q2 Net Profit Dips 67 Percent to ₹9.13 Crore

Drug firm AstraZeneca Pharma India reported a 66.65 percent dip in its net profit to Rs 9.13 crore for the quarter ended September 30, 2018.The Company had posted a net profit of Rs 27.38 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a filing to BSE. Company’s total revenue for the quarter under consideration stood at Rs 164.71 crore. It was Rs 166.75 crore for the same period year ago. – Money Control